NIAB Molecular Biology/Immunology RA Vacancy


Advertisement No. 03/2020

Applications are invited from suitable candidate for filling up the following position at National Institute of Animal Biotechnology (NIAB), Hyderabad

One position of Project Associate-II against the following project: 

(i) DBT funded project entitled “Genomics assisted pathobiology to identify novel targets for diagnosis and therapeutic intervention(s) of Japanese encephalitis and Leptospirosis”.

PI: Dr. Ravi Gandham, Co-PIs- Dr. Subeer S. Majumdar, Dr. Syed M. Faisal, Dr. Pankaj Suman. 

Eligibility: Master’s Degree in Life Science or Agricultural Sciences / MVSc or bachelor’s degree in Engineering or Technology or Medicine from a recognized University or equivalent; and 2 years’ experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations and Scientific activities and services as per DST OM No. SR/S9/Z-05/2019 dated 21.08.2019. 

Fellowship amount: Rs. 35000/-PM +24% HRA (if applicable) as per the DST guidelines. 

Experience: Candidate with experience in Molecular biology and Immunological techniques, genomics, proteomics, bioinformatics and animal (mice, hamster) handling is desirable. 

Candidates having prior experience in working any virus will be preferred. 

Age: 35 years (Relaxation is admissible in case of SC/ST/OBC candidates as per Government instructions) 

Applications are to be filled ONLINE. Online link for submission of application is available from 13-02-2020 and the last date is 04-03-2020 by 5 PM.  Candidates are advised to fill the online application form in sufficient time before the last date to avoid last minute technical issues. Shortlisted candidates will be called for an interview prior to selection. TA/DA will not be paid for attending the interview. No need to send hard copy. Interim enquiries will not be entertained. 

More Info: http://www.niab.org.in/Notifications_3_2020.aspx

To Get All Updates from helpBIOTECH, Subscribe Now by Email

Post a comment

0 Comments